SCHEMBL31301320

SCHEMBL31301320

Cc1nccc(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
LMNA P02545 2/20 0.54
TRPV3 Q8NET8 1/20 0.48
HTT P42858 1/20 0.48
KIF11 P52732 1/20 0.47
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
TOP1 P11387 2/20 0.44
THRB P10828 1/20 0.43
GABBR2 O75899 3/20 0.42
GABBR1 Q9UBS5 3/20 0.42
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
CDK2 P24941 1/20 0.41
RAD51 Q06609 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15888381 1.00 KDM4E (0.54) KDM4ELMNATRPV3HTTKIF11
SCHEMBL28267570 0.81 MEN1 (0.54) KDM4ETRPV3KIF11POLBTOP1
SCHEMBL13273287 0.80 KMO (0.62) KDM4ELMNAALDH1A1POLBIDO1
SCHEMBL2404944 0.79 KDM4E (0.59) KDM4ELMNATRPV3HTTALDH1A1
SCHEMBL10194257 0.79 KDM4E (0.62) KDM4ELMNAHTTALDH1A1POLB
SCHEMBL16352369 0.79 KDM4E (0.58) KDM4ELMNAHTTALDH1A1POLB
SCHEMBL16538634 0.79 HSP90AA1 (0.59) KDM4ETRPV3HTTKIF11ALDH1A1
SCHEMBL30885864 0.79 KIF11 (0.47) KDM4ETRPV3KIF11TOP1IDO1
SCHEMBL15534703 0.79 KIF11 (0.47) KDM4ETRPV3KIF11ALDH1A1POLB
SCHEMBL27616958 0.79 KIF11 (0.47) KDM4ETRPV3KIF11TOP1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS KDM4E 3780/4885LMNA 2403/4885TRPV3 1941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.